Literature DB >> 35546384

Brachytherapy for central nervous system tumors.

Evan D Bander1, Jonathan P S Knisely2, Theodore H Schwartz3,4.   

Abstract

Radiation is a mainstay of treatment for central nervous system (CNS) tumors. Brachytherapy involves the placement of a localized/interstitial radiation source into a tumor or resection bed and has distinct advantages that can make it an attractive form of radiation when used in the appropriate setting. However, the data supporting use of brachytherapy is clouded by variability in radiation sources, techniques, delivered doses, and trial designs. The goal of this manuscript is to identify consistent themes, review the highest-level evidence and potential indications for brachytherapy in CNS tumors, as well as highlight avenues for future work. Improved understanding of the underlying biology, indications, complications, and evolving industry-academic collaborations, place brachytherapy on the brink of a resurgence.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Brachytherapy; Brain Metastases; Cesium; Glioma; Iodine; Meningioma; Radiation

Mesh:

Year:  2022        PMID: 35546384     DOI: 10.1007/s11060-022-04026-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  81 in total

Review 1.  The radiobiology and physics of brachytherapy.

Authors:  R L Crownover; D A Wilkinson; M S Weinhous
Journal:  Hematol Oncol Clin North Am       Date:  1999-06       Impact factor: 3.722

2.  TREATMENT OF INTRASELLAR TUMOURS BY RADON.

Authors:  W O Lodge
Journal:  Br Med J       Date:  1936-12-19

Review 3.  Intraoperative brachytherapy for resected brain metastases.

Authors:  Sean S Mahase; Kristina Navrazhina; Theodore H Schwartz; Bhupesh Parashar; A Gabriella Wernicke
Journal:  Brachytherapy       Date:  2019-03-06       Impact factor: 2.362

4.  Timing of Adjuvant Fractionated Stereotactic Radiosurgery Affects Local Control of Resected Brain Metastases.

Authors:  Diana A Roth O'Brien; Phillip Poppas; Sydney M Kaye; Sean S Mahase; Anjile An; Paul J Christos; Benjamin Liechty; David Pisapia; Rohan Ramakrishna; A Gabriella Wernicke; Jonathan P S Knisely; Susan Pannullo; Theodore H Schwartz
Journal:  Pract Radiat Oncol       Date:  2021-02-10

Review 5.  Brachytherapy for brain tumors.

Authors:  Todd W Vitaz; Peter C Warnke; Viviane Tabar; Philip H Gutin
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

6.  Surgical Technique and Clinically Relevant Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases.

Authors:  A Gabriella Wernicke; Stefanie P Lazow; Shoshana Taube; Menachem Z Yondorf; Ilhami Kovanlikaya; Dattatreyudu Nori; Paul Christos; John A Boockvar; Susan Pannullo; Philip E Stieg; Theodore H Schwartz
Journal:  Oper Neurosurg (Hagerstown)       Date:  2015-08-01       Impact factor: 2.703

7.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

Authors:  R A Patchell; P A Tibbs; W F Regine; R J Dempsey; M Mohiuddin; R J Kryscio; W R Markesbery; K A Foon; B Young
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

9.  Durable 5-year local control for resected brain metastases with early adjuvant SRS: the effect of timing on intended-field control.

Authors:  Evan D Bander; Melissa Yuan; Anne S Reiner; Katherine S Panageas; Åse M Ballangrud; Cameron W Brennan; Kathryn Beal; Viviane Tabar; Nelson S Moss
Journal:  Neurooncol Pract       Date:  2021-01-21

10.  Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.

Authors:  Anita Mahajan; Salmaan Ahmed; Mary Frances McAleer; Jeffrey S Weinberg; Jing Li; Paul Brown; Stephen Settle; Sujit S Prabhu; Frederick F Lang; Nicholas Levine; Susan McGovern; Erik Sulman; Ian E McCutcheon; Syed Azeem; Daniel Cahill; Claudio Tatsui; Amy B Heimberger; Sherise Ferguson; Amol Ghia; Franco Demonte; Shaan Raza; Nandita Guha-Thakurta; James Yang; Raymond Sawaya; Kenneth R Hess; Ganesh Rao
Journal:  Lancet Oncol       Date:  2017-07-04       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.